<SEC-DOCUMENT>9999999995-21-000934-index.html : 20210315
<SEC-HEADER>9999999995-21-000934.hdr.sgml : 20210315
<ACCEPTANCE-DATETIME>20210315001539
ACCESSION NUMBER:		9999999995-21-000934
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210312
DATE AS OF CHANGE:		20210315
EFFECTIVENESS DATE:		20210312

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acer Therapeutics Inc.
		CENTRAL INDEX KEY:			0001069308
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				320426967
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-253838
		FILM NUMBER:		21739656

	BUSINESS ADDRESS:	
		STREET 1:		ONE GATEWAY CENTER (300 WASHINGTON ST.)
		STREET 2:		SUITE 351
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02458
		BUSINESS PHONE:		(844) 902-6100

	MAIL ADDRESS:	
		STREET 1:		ONE GATEWAY CENTER (300 WASHINGTON ST.)
		STREET 2:		SUITE 351
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02458

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Opexa Therapeutics, Inc.
		DATE OF NAME CHANGE:	20060616

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PharmaFrontiers Corp.
		DATE OF NAME CHANGE:	20051011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHARMAFRONTIERS CORP
		DATE OF NAME CHANGE:	20040816
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>